Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs Tesla, Inc. (TSLA) Price & Performance

Nuwellis IncTrade
Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs Tesla, Inc. — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Tesla, Inc. trades at $365.57 (market cap $1.45T). The key difference: Tesla, Inc. is far larger — about 580000× Nuwellis Inc's market cap, and Tesla, Inc. is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

NUWETSLA
Market Cap
$2.50M$1.45T
Sector
TechnologyConsumer Cyclical
52-Week High
$164.50$489.88
52-Week Low
$0.73$298.16
Enterprise Value
-$1.21M$1.43T

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.

While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.

Tesla, Inc.

Tesla (TSLA) trades at $368.16, up 3.98% today, amid a bullish technical signal and recent earnings beats despite a Q2 2026 miss. The stock shows elevated valuation multiples with a P/E of 340.89 and P/S of 12.57, while profitability metrics like a 3.67% net income margin reflect competitive pressures. Positive developments include regulatory approval for driver-assistance software in Europe and a potential cheaper EV launch, though cash flow trends indicate heavy investment spending.

The outlook balances innovation potential in autonomy and energy against valuation concerns and execution risks. Near-term catalysts include Q3 2026 earnings, with the consensus price target of $398.38 suggesting modest upside. Key risks are slowing auto demand, high capex, and reliance on future technology adoption to justify current premiums.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.

Read more on TSLA